Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Implementing disease management in community pharmacy practice

D Holdford1, D T Kennedy, P Bernadella

  • 1School of Pharmacy, VCU, Medical College of Virginia Campus, Richmond, USA.

Clinical Therapeutics
|May 20, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Economics of antihypertensive therapy in the elderly.

Drugs & aging·2001
Same author

Role of coenzyme Q10 in chronic heart failure, angina, and hypertension.

Pharmacotherapy·2001
Same author

Results of a community pharmacy-based breast cancer risk-assessment and education program.

Pharmacotherapy·2001
Same author

Children and smoking.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2001
Same author

Obesity: managing comorbidities of the disease.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2000
Same author

The impact of disease management on outcomes and cost of care: a study of low-income asthma patients.

Inquiry : a journal of medical care organization, provision and financing·2000
Same journal

Reimagining Representation Across the Clinical Research Ecosystem: Part II of a Specialty Update on Advancing Diversity, Racial Equity, and Inclusion in Clinical Research.

Clinical therapeutics·2026
Same journal

Combined Effects of Nicorandil and Enhanced External Counterpulsation on Coronary Microcirculation and Exercise Capacity in Patients With Coronary Slow Flow Phenomenon: A Randomized, Controlled, 3-Arm Trial.

Clinical therapeutics·2026
Same journal

Phase 1 Study Evaluating Gefurulimab Pharmacokinetics and Safety Following Delivery Via Autoinjector or Prefilled Syringe With Needle Safety Device in Healthy Adults.

Clinical therapeutics·2026
Same journal

Evaluating Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Associated With Newer Antiseizure Medications Using FAERS and JADER Combined With Bioinformatics Exploration.

Clinical therapeutics·2026
Same journal

Diversity: A Medical Research Imperative.

Clinical therapeutics·2026
Same journal

LOARGYS (pegzilarginase-nbln).

Clinical therapeutics·2026
See all related articles

Disease management (DM) provides integrated, evidence-based care for specific diseases, focusing on patient outcomes. Community pharmacists play a key role in DM programs, enhancing patient care and accessibility.

Area of Science:

  • Health Services Research
  • Pharmaceutical Practice
  • Public Health

Background:

  • Disease management (DM) is a structured approach to patient care, emphasizing evidence-based interventions and outcomes.
  • DM targets specific patient populations, integrating services across various healthcare settings and professionals.
  • It differs from pharmaceutical care by focusing on diagnosed diseases rather than solely on drug-related problems or risk factors.

Purpose of the Study:

  • To define the core components and implementation steps of disease management programs.
  • To highlight the role of community pharmacists in disease management initiatives.
  • To illustrate the application of DM principles using a smoking cessation program example.

Main Methods:

  • Outlined a five-step process for establishing DM programs: population identification, resource assessment, indicator definition, implementation, and impact assessment.

Related Experiment Videos

  • Utilized a case study of a smoking cessation program in a retail pharmacy chain to demonstrate practical application.
  • Emphasized the use of the best available scientific evidence in program design and execution.

    • Main Results:

    • Disease management programs require strategic planning, resource evaluation, and outcome measurement for success.
    • Community pharmacy settings are suitable for implementing DM programs due to pharmacist accessibility and involvement in drug therapy.
    • A smoking cessation program demonstrated the feasibility and potential impact of DM in community practice.

    Conclusions:

    • Pharmacists are integral to the evolution and success of disease management, particularly in community settings.
    • Effective DM requires a systematic approach, integrating services and focusing on measurable patient outcomes.
    • The expansion of DM in managed care underscores the importance of community pharmacist involvement.